MSB 5.50% $1.38 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-299

  1. 2,124 Posts.
    lightbulb Created with Sketch. 45
    If we look at what happened with ODAC meeting they were against Rynocil until it was explained by MSB at the meeting then 9-1.
    FDA may be the same , the 1 against vote carrying their voice to the FDA, which may once again be overturned by MSB interactive discussions.
    Lets hope any way. (for the sake of some very sick children if nothing else).
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.